Christopher R. Flowers, MD, M.S.
MD Anderson Cancer Centre, Houston, Texas
Christopher R. Flowers, MD, M.S.MD Anderson Cancer Centre, Houston, Texas
Christopher R. Flowers, MD, is Professor and Chair of the Department of Lymphoma and Myeloma at MD Anderson Cancer Center. He has focused on specialized care for patients with lymphoid malignancies. Dr. Flowers graduated from Stanford University from the human biology and humanities honors programs. He remained at Stanford where he completed medical school and received a master’s degree in medical information sciences. After medical school, he completed an internal medicine residency at the University of Washington. He continued his research training in Seattle through the Robert Wood Johnson Clinical Scholars Program and oncology fellowship at the Fred Hutchinson Cancer Research Center.
Judith Trotman, MBChB, FRACP, FRCPA
Concord Hospital, Sydney
Judith Trotman, MBChB, FRACP, FRCPAConcord Hospital, Sydney
Professor Judith Trotman, MBChB, FRACP, FRCPA, Spec Cert in Clinical Research (Oncology), is Head of the Hematology Department, Concord Repatriation General Hospital, University of Sydney, AU. An active clinician researcher she has particular expertise in the management of lymphoid malignancies. Professor Trotman is a lymphoma clinician researcher who provides global leadership in charting the role of PET scanning in lymphoma. She is committed to embedding quality clinical trials into clinical care and to the implementation of research findings into practice as evidenced by her successful MBS listing of PET for indolent lymphomas. She has developed a number of digital research initiatives in collaborations with patients, including ClinTrial Refer and the WhiMSICAL study.
MD Anderson Cancer Center, Texas
Loretta NastoupilMD Anderson Cancer Center, Texas
Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Lymphoma Outcomes Database, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Section Chief, New Drug Development, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
The University of British Columbia
Laurie SehnThe University of British Columbia
Dr Laurie Sehn is currently Clinical Professor with the BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, Canada. She has been a medical oncologist and clinical investigator at BC Cancer since 1998, and is currently the Chair of the Lymphoma Tumour Group. Dr Sehn graduated from McGill Medical School, Montreal, Canada and received her training in Internal Medicine at Columbia Presbyterian Medical Center, Columbia University, New York, USA.